ArticleBMC medical informatics and decision making2025
AI-assisted haematology: machine learning-based prediction of iron-deficiency anaemia from reticulocyte maturation indices.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIron-deficiency anaemia (IDA) is the most prevalent hematological disorder globally, significantly impairing physical capacity and cognitive development. Early detection is crucial; however, conventional diagnostic methods often have limitations. Machine learning (ML) can enhance predictive accuracy by analyzing complex hematological parameters, including reticulocyte maturation indices. This study aimed to develop and compare multiple ML algorithms for IDA prediction and to identify the most effective model for potential clinical use.
methodsThis retrospective cross-sectional study examined anonymized data from 444 adults (20–59 years) at Shahid Mohammadi Hospital, Iran, collected between November 2024 and January 2025. Five supervised ML algorithms including random forest (RF), support vector machine (SVM), decision tree (DT), naive Bayes (NB), and CatBoost were trained using a 70/30 train–test split. Stratified 10-fold cross-validation and the synthetic minority oversampling technique (SMOTE) were applied for hyperparameter optimization and class-imbalance adjustment. Model performance was evaluated using accuracy, sensitivity, specificity, F1-score, AUC-ROC, and the Matthews correlation coefficient (MCC). SHapley additive explanations (SHAP) values were used to characterize feature importance.
resultsDual-criteria labelling identified 350 of 444 participants (79%) as having IDA. In 10-fold cross-validation of the training set (n = 310), CatBoost achieved the highest AUC-ROC (0.98), followed by RF (0.97), NB (0.91), SVM (0.90), and DT (0.88). On the independent test set (n = 134), CatBoost maintained superior performance, with an AUC-ROC of 0.93 (95% confidence interval (CI) 0.89–0.97), sensitivity of 0.92 (95% CI 0.88–0.96), specificity of 0.86 (95% CI 0.74–0.94), and MCC of 0.73 (95% CI 0.60–0.84). SHAP analysis identified haemoglobin (HGB), haematocrit (HCT), and red blood cell count (RBC) as the most influential predictors, underscoring the model’s physiological interpretability.
conclusionML models, especially CatBoost, accurately predict IDA using standard blood tests and reticulocyte indices. The use of explainable artificial intelligence (AI) enables physiologically interpretable predictions, which can significantly support earlier detection, more efficient resource use, and improved clinical decision-making. These results underscore the potential of incorporating reticulocyte maturation markers into ML-based diagnostic tools in hematology, offering a promising future of more efficient and effective resource utilization in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.